Search | Schedule | Concurrent Oral Session Grid | Author Index | eBook | Personal Scheduler

Author Index: K

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Kadish, A. H.
F-4   HARNESSING THE POWER OF BAYESIAN STATISTICS AND PATIENT-LEVEL DATA TO PREDICT THE EFFECTIVENESS OF IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) THERAPY IN PATIENT SUBGROUPS
Kahn, V. C.
DOES IT TAKE LONGER TO DO BETTER INFORMED DECISION MAKING IN EARLY STAGE PROSTATE CANCER?

DO PATIENTS GET WHAT THEY WANT: STABILITY OF PREFERENCES BEFORE AND FOLLOWING A PHYSICIAN VISIT

K-4   SUPPORTING PATIENT VALUES: A SYSTEMATIC REVIEW OF VALUES CLARIFICATION EXERCISES
Kaimal, A.
H-6   FRESH VERSUS ELECTIVE FROZEN-THAWED EMBRYO TRANSFER FOR WOMEN UNDERGOING IN VITRO FERTILIZATION: A DECISION ANALYSIS
Kamel, H.
N-4   TREAT, TEST, OR NEITHER? COST-EFFECTIVENESS OF CEREBROVASCULAR RESERVE IMAGING TO GUIDE TREATMENT OF CAROTID STENOSIS FOR STROKE PREVENTION
Kamin, D.
PRE-MEETING DINNER SYMPOSIUM: INFLUENCING POLICY AND CLINICAL PRACTICE: CASE STUDIES ACROSS THE CANCER CARE CONTINUUM
Kaphingst, K.
EFFECTIVE COMMUNICATION TO IMPROVE DECISION MAKING ABOUT HEALTH CARE PLANS
Kardel, P.
UTILIZATION PATTERNS OF ADALIMUMAB, ETANERCEPT, AND GOLIMUMAB IN RHEUMATOID ARTHRITIS

DEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF RHEUMATOID ARTHRITIS PATIENTS BEFORE INITIATING ADALIMUMAB, ETANERCEPT OR GOLIMUMAB
Karmarkar, T.
DOES PUBLIC REPORTING HAVE AN IMPACT ON HEALTHCARE DISPARITIES? A SYSTEMATIC REVIEW OF CLAIMS AND EVIDENCE GAPS
Karnawat, S.
EFFECT OF WEIGHT LOSS INDUCED BY PHENTERMINE AND TOPIRAMATE EXTENDED-RELEASE ON ANNUAL MEDICATION COSTS IN OBESE AND OVERWEIGHT INDIVIDUALS

CHANGES IN ANNUAL MEDICATION COSTS ASSOCIATED WITH WEIGHT LOSS INDUCED BY PHENTERMINE AND TOPIRAMATE EXTENDED-RELEASE ACROSS BODY-MASS INDEX LEVELS IN OBESE AND OVERWEIGHT INDIVIDUALS

N-3   EFFECT OF MAGNITUDE OF WEIGHT LOSS ON ANNUAL ANTIHYPERTENSIVE, LIPID-LOWERING, AND ANTIDIABETIC MEDICATION COST IN OBESE AND OVERWEIGHT INDIVIDUALS
Kasper, K.
PREFERENCE ELICITATION TOOL FOR ABNORMAL UTERINE BLEEDING TREATMENT: A RANDOMIZED CONTROLLED TRIAL
Kattan, M. W.
PERSONALIZED DECISION MAKING USING POPULATION REGISTRIES: A PRACTICAL APPROACH

USING MODELING TO MAKE BETTER MEDICAL DECISIONS
Katz, M.
FINANCIAL CONCERNS AND PSYCHOSOCIAL FACTORS ASSOCIATED WITH DECISION MAKING ABOUT CLINICAL TRIALS
Kaufman, D.
OVERLAP AND THE EFFICIENCY OF DISCRETE-CHOICE EXPERIMENTS: EVIDENCE FROM A RANDOMIZED EXPERIMENT
Kealey, E.
USING MEDICAID CLAIMS DATA TO GENERATE PERSONALIZED HEALTH MESSAGES IN A WEB-BASED SHARED DECISION MAKING TOOL (MYPSYCKES): PATIENT ENDORSEMENT OF INDIVIDUALLY TAILORED VERSUS STANDARDIZED MENTAL HEALTH MEDICATION TREATMENT CONCERNS
Keefe, E.
DEVELOPMENT AND VALIDATION OF A COMPUTER-BASED ALGORITHM TO IDENTIFY FOREIGN-BORN PATIENTS WITH HIV INFECTION FROM THE ELECTRONIC MEDICAL RECORD
Kelly-Blake, K.
CAN AN INTERACTIVE DECISION AID IMPROVE SHARED DECISION MAKING? PRELIMINARY RESULTS FROM DATES (DECISION AID TO TECHNOLOGICALLY ENHANCE SHARED DECISION MAKING)
Kempe, A.
VARIATION IN GASTROSTOMY TUBE PROCEDURES: A FOUR-STATE COMPARISON OF PEDIATRIC MEDICAID DATA
Kessler, J.
THE VALUE OF PRIORITIZATION OF ANTIRETROVIRAL BASED PRE-EXPOSURE PROPHYLAXIS IN NEW YORK CITY (NYC)
Khojandi, A.
L-2   DYNAMIC ABANDON/EXTRACT DECISIONS FOR FAILED CARDIAC LEADS
Kim, D. D.
FORECASTING BODY MASS INDEX DISTRIBUTIONS AMONG THE US CHILDREN USING A LONGITUDINAL DATASET
Kim, J. J.
USING BIVARIATE META-REGRESSION MODELS TO ANALYZE CERVICAL CANCER SCREENING TEST PERFORMANCE

C-3   EXPANDING THE NORWEGIAN HPV VACCINE PROGRAM TO INCLUDE BOYS

D-1   CERVICAL CANCER SCREENING IN RESOURCE-LIMITED SETTINGS: EVALUATING TRADEOFFS BETWEEN TEST PERFORMANCE AND PROGRAMMATIC CONSIDERATIONS

WELL THAT WAS HARD…DECISION MAKING IN COMPLEX CLINICAL ENCOUNTERS

TRA1-4   INCREMENTAL BENEFITS AND COST-EFFECTIVENESS OF A CATCH-UP HPV VACCINATION PROGRAM IN NORWAY
Kim, S. Y.
THE VALUE OF REDUCING UNCERTAINTIES ABOUT VACCINATION PROGRAMS IN LOW- AND MIDDLE-INCOME COUNTRIES

O-4   EXPANDING THE RANGE OF COMPARATORS FOR COST-EFFECTIVENESS ANALYSES OF VACCINES: THE EXAMPLE OF A POTENTIAL GROUP B STREPTOCOCCAL (GBS) VACCINE PROGRAM FOR PREGNANT WOMEN IN SOUTH AFRICA
Kimmel, A. D.
IDENTIFYING THE CHALLENGES TO UNDERSTANDING EVIDENCE AND DECISIONS
Kimmelman, J.
WHAT INFORMATION IS MISSING FROM INFORMED CONSENT DOCUMENTS?

DEVELOPING A DECISION AID TO HELP PROVIDE INFORMED CONSENT FOR RESEARCH; A USER-CENTERED DESIGN APPROACH
Kinzy, T.
FINANCIAL CONCERNS AND PSYCHOSOCIAL FACTORS ASSOCIATED WITH DECISION MAKING ABOUT CLINICAL TRIALS
Kirpalani, H.
E-4   HOW SHOULD COMPLEX DATA BE PRESENTED TO HELP PATIENTS MAKE INFORMED DECISIONS?
Klemp, M.
A PARADIGM SHIFT IN ANTICOAGULATION OR TOO SOON TO CONCLUDE ON COST-EFFECTIVENESS OF NEW ORAL ANTICOOAGULANTS?

C-5   DO WE NEED COMPARATIVE EFFECTIVENESS RESEARCH ON THE NEW ORAL ANTICOAGULANTS?
Kluibenschaedl, M.
METHODOLOGICAL CHARACTERISTICS OF DECISION-ANALYTIC MODELING STUDIES FOR THE TREATMENT OF MULTIPLE MYELOMA
Knies, S.
ECONOMIC BENEFITS OF SUBSIDIZING IN-VITRO FERTILIZATION FROM THE GOVERNMENT PERSPECTIVE IN BELARUS, KAZAKHSTAN, AND UKRAINE
Knight, S. J.
DO PATIENTS GET WHAT THEY WANT: STABILITY OF PREFERENCES BEFORE AND FOLLOWING A PHYSICIAN VISIT

J-1   RACIAL DIFFERENCES IN TREATMENT PREFERENCES AFTER USING A LOW VERSUS HIGH LITERACY PROSTATE CANCER DECISION AID
Ko, D. T.
A-3   CHARACTERISTICS OF MULTI-DISCIPLINARY HEART FAILURE CLINICS THAT PREDICT 1-YEAR CUMULATIVE HEALTH CARE COSTS: A POPULATION-BASED STUDY

TRA1-3   IMPACT OF INCREASING WAIT TIMES ON THE EFFECTIVENESS OF TRANSCATHETER AORTIC-VALVE REPLACEMENT (TAVR) IN HIGH-RISK AND INOPERABLE PATIENTS WITH SEVERE AORTIC DISEASE: A DISCRETE EVENT SIMULATION MODEL
Koh, G. C. H.
STRATEGIC INVESTMENT TO INCREASE UTILIZATION OF STROKE REHABILITATION SERVICES: INSIGHTS FROM A SYSTEM DYNAMICS MODEL
Kohn, M. A.
ADVANCED EVIDENCE-BASED DIAGNOSIS (ROC CURVES, INTERVAL LIKELIHOOD RATIOS, AND BIAS IN TEST ACCURACY STUDIES)
Kong, C. Y.
I-1   SELECTING BEST-FITTING INPUTS IN MUTLI-TARGET MODEL CALIBRATION AND IMPLICATIONS FOR COST-EFFECTIVENESS ANALYSIS
Kong, N.
IDENTIFYING NON-STANDARDIZATION OF PHYSICIAN BEHAVIORS IN PATIENT-PHYSICIAN COMMUNICATION AND SHARED DECISION MAKING: A CLUSTERING ANALYSIS APPROACH
Konheim-Kalkstein, Y. L.
DECIDING TO UNDERGO A TRIAL OF LABOR AFTER A PREVIOUS CESAREAN: SOURCES OF INFLUENCE
Korfage, I. J.
D-4   THE EFFECT OF DIFFERENT UTILITY ASSUMPTIONS ON THE COST-EFFECTIVENESS OF CERVICAL CANCER SCREENING
Kostopoulou, O.
COMMITTEE & INTEREST GROUP MEETINGS: DIAGNOSTIC ERRORS INTEREST GROUP

INFLUENCE OF DISEASE PREVALENCE AND AN ALTERNATIVE EXPLANATION ON EARLY CANCER DETECTION IN FAMILY MEDICINE

THE PSYCHOLOGY OF MEDICAL DIAGNOSIS
Kozma, C.
ABIRATERONE ACETATE AND PREDNISONE REFILL CONSISTENCY IN METASTATIC CASTRATION RESISTANT PROSTATE CANCER PATIENTS
Krabbe, P.
VALUATION OF DEPRESSION: DISCREPANCIES BETWEEN INDIVIDUALS WITH AND WITHOUT DEPRESSION
Krahn, M. D.
ECONOMIC EVALUATION OF MENINGOCOCCAL SEROGROUP B CHILDHOOD VACCINATION IN ONTARIO, CANADA

DEVELOPING THE BLADDER UTILITY SYMPTOM SCALE (BUSS): A MULTIATTRIBUTE HEALTH STATE CLASSIFICATION SYSTEM FOR BLADDER CANCER

A-3   CHARACTERISTICS OF MULTI-DISCIPLINARY HEART FAILURE CLINICS THAT PREDICT 1-YEAR CUMULATIVE HEALTH CARE COSTS: A POPULATION-BASED STUDY

N-6   THE HEPATITIS C DRUG PIPELINE: COLLABORATION BETWEEN ACADEMIC AND HTA AGENCY PARTNERS TO DEVELOP AN EARLY ECONOMIC MODEL
Krämer, A.
D-2   THE BENEFIT-HARM FRONTIER OF HPV PRIMARY SCREENING FOR CERVICAL CANCER IN GERMANY: ESTIMATES FROM A SYSTEMATIC DECISION -ANALYSIS
Kreuter, M.
EFFECTIVE COMMUNICATION TO IMPROVE DECISION MAKING ABOUT HEALTH CARE PLANS
Krieger, H. A.
FRAMING EFFECTS ON PHYSICIANS' JUDGMENT AND DECISION MAKING: A NATIONAL SURVEY OF INTERNAL MEDICINE PHYSICIANS IN THE UNITED STATES
Kristiansen, I. S.
GENERAL PRACTITIONERS' PREFERENCES FOR CLINICAL WORK IN THE PHYSICIAN'S OFFICE VERSUS PUBLIC HEALTH TASKS

MEAN SURVIVAL CAN BE RELIABLY PREDICTED FROM MEDIAN SURVIVAL AFTER A CANCER DIAGNOSIS WITH POOR PROGNOSIS

C-3   EXPANDING THE NORWEGIAN HPV VACCINE PROGRAM TO INCLUDE BOYS

M-6   RISK COMMUNICATION USING ABSOLUTE RISK REDUCTION OR PROLONGATION OF LIFE: DOES IT INFLUENCE REAL LIFE DECISIONS ABOUT CHOLESTEROL LOWERING MEDICATION?

TRA1-4   INCREMENTAL BENEFITS AND COST-EFFECTIVENESS OF A CATCH-UP HPV VACCINATION PROGRAM IN NORWAY
Kronborg, M. L.
MEAN SURVIVAL CAN BE RELIABLY PREDICTED FROM MEDIAN SURVIVAL AFTER A CANCER DIAGNOSIS WITH POOR PROGNOSIS
Krousel-Wood, M. A.
ASSOCIATION OF METFORMIN USE WITH INCIDENCE AND MORTALITY OF PROSTATE CANCER: A META-ANALYSIS
Kruger, J.
A NOVEL MULTI-BEHAVIOUR HEALTH ECONOMIC DECISION MODEL TO EVALUATE COST-EFFECTIVENESS OF PUBLIC HEALTH INTERVENTIONS IN THE UK
Kruitwagen, R. F. P. M.
DUTCH VERSION OF THE SDM-Q-9 AND SDM-Q-DOC: GOOD RELIABILITY AND MIXED RESULTS REGARDING VALIDITY
Kudenchuk, P. J.
F-4   HARNESSING THE POWER OF BAYESIAN STATISTICS AND PATIENT-LEVEL DATA TO PREDICT THE EFFECTIVENESS OF IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) THERAPY IN PATIENT SUBGROUPS
Kulkarni, G.
DEVELOPING THE BLADDER UTILITY SYMPTOM SCALE (BUSS): A MULTIATTRIBUTE HEALTH STATE CLASSIFICATION SYSTEM FOR BLADDER CANCER
Kumar, A.
EVALUATION OF PHYSICIANS' COGNITIVE STYLES
Kuntz, K. M.
COST-EFFECTIVENESS OF URATE LOWERING STRATEGIES FOR THE MANAGEMENT OF GOUT

EXAMINING THE EFFECT OF CORRELATED PARAMETERS ON REGRESSION METAMODELING

BUILDING CORRELATIONS AMONG MODEL PARAMETERS: A PRACTICAL APPROACH

TRADE-OFFS BETWEEN EFFICACY AND CARDIAC TOXICITY OF ADJUVANT CHEMOTHERAPY IN EARLY-STAGE BREAST CANCER PATIENTS. DO COMPETING RISKS MATTER?

L-6   MEASURING DECISION SENSITIVITY WITH MULTINOMIAL LOGISTIC REGRESSION METAMODELING

ON THE FRONTIER: ADVANCES IN METHODS RELEVANT TO COST-EFFECTIVENESS

O-6   EXPECTED VALUE OF SAMPLE INFORMATION FOR CORRELATED DATA: A PRACTICAL APPROACH

TRA2-5   CLINICAL BENEFITS OF CONTRALATERAL PROPHYLACTIC MASTECTOMY FOR WOMEN WITH UNILATERAL EARLY-STAGE BREAST CANCER
Kuppermann, M.
TRIALS AND INTERVENTIONS FOR RISK REDUCTION

TRA2-2   RANDOMIZED TRIAL OF AN INFORMED FREE CHOICE APPROACH TO PRENATAL TESTING AMONG WOMEN OF VARYING LITERACY LEVELS
Kurzthaler, C.
METHODOLOGICAL CHARACTERISTICS OF DECISION-ANALYTIC MODELING STUDIES FOR THE TREATMENT OF MULTIPLE MYELOMA
Kwoh, C. K.
RACIAL DIFFERENCES IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) PATIENTS' TREATMENT PREFERENCES: A TWO-SITE STUDY
Kwong, J.
ECONOMIC EVALUATION OF MENINGOCOCCAL SEROGROUP B CHILDHOOD VACCINATION IN ONTARIO, CANADA
Kymes, S.
COMMITTEE & INTEREST GROUP MEETINGS: MEMBERSHIP COMMITTEE
Kyutoku, Y.
TRANSLATION AND APPLICATION OF THE NUMERACY UNDERSTANDING IN MEDICINE INSTRUMENT IN JAPAN
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z